Remove Authorization Requirement Adjust Chronic Prescription

Removed the requirement that dose or frequency adjustments apply when the prescription drug is a chronic maintenance drug as defined in Section 12-280-103 (9.5).

Updated the bill status header from 'Rerevised' to 'Revised' and changed the amendment status from 'Amended 3rd Reading' to 'Amended on Second Reading' in the Second House.

Reduced the number of House sponsors listed in the bill text, removing names from the House sponsorship section.

Added official session headers, committee assignments, and reading dates to document the bill's legislative history and current status.

Reorganized the bill text structure to include proper formatting for amendments, with line numbers and amendment indicators added.

Removed preliminary notes about bill signatures and status that were intended for external reference rather than inclusion in the final text.

Reordered and renumbered sections to align with standard legislative formatting conventions.

Added 10 new Senate sponsors: Amabile, Ball, Carson, Catlin, Frizell, Liston, Pelton B., Pelton R.

Updated bill summary header to indicate '3rd Reading Unamended' dated April 28, 2025, replacing the previous 'Engrossed' status.

Added a requirement that dose or frequency adjustments must be consistent with available evidence-based guidelines before proceeding without prior authorization.

Modified the eligibility criteria for providers to adjust chronic maintenance drug doses by adding the evidence-based guideline condition.